2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | 20.960 | 15.629 | 41.827 | 37.386 | 40.966 | 45.024 | 14.188 |
Total Income - EUR | - | - | - | 21.321 | 15.633 | 42.768 | 38.584 | 42.109 | 45.065 | 14.805 |
Total Expenses - EUR | - | - | - | 4.576 | 14.005 | 23.437 | 13.245 | 13.637 | 19.791 | 29.640 |
Gross Profit/Loss - EUR | - | - | - | 16.745 | 1.628 | 19.331 | 25.340 | 28.472 | 25.274 | -14.835 |
Net Profit/Loss - EUR | - | - | - | 16.106 | 1.472 | 18.903 | 24.970 | 28.050 | 24.833 | -14.983 |
Employees | - | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Arux Pharma Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | - | - | 12 | 0 | 0 | 0 | 18 | 0 | 0 |
Current Assets | - | - | - | 20.996 | 23.086 | 63.364 | 75.854 | 96.640 | 129.051 | 42.279 |
Inventories | - | - | - | 0 | 0 | 0 | 62 | 0 | 67 | 0 |
Receivables | - | - | - | 10.919 | 1.751 | 4.117 | 20.127 | 4.076 | 276 | 1.629 |
Cash | - | - | - | 10.077 | 21.335 | 59.247 | 55.665 | 92.564 | 128.709 | 40.650 |
Shareholders Funds | - | - | - | 16.149 | 17.325 | 35.893 | 60.182 | 86.898 | 24.882 | 9.824 |
Social Capital | - | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | - | 4.876 | 5.777 | 27.490 | 15.693 | 9.760 | 104.170 | 32.456 |
Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7320 - 7320" | |||||||||
CAEN Financial Year |
7320
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Arux Pharma Srl